Zagkla Elina Styliani

Subspecialty Certification

Allergology
Berlin Medical Association, Germany (2025)

Subspecialty Certification

Pediatric Pulmonology
Berlin Medical Association, Germany (2024)

Doctoral Dissertation

PhD Candidate since 2024, Department of Pediatrics with a Focus on Pediatric Pulmonology and Immunology, Charité – Universitätsmedizin Berlin, Germany.
Research Topic: “Comparison of the Effects of Isotonic and Hypertonic Saline Inhalation on Magnetic Resonance Imaging of the Paranasal Sinuses in Infants and Children with Cystic Fibrosis.”
Supervisors: Prof. Dr. med. M. Stahl and Prof. Dr. med. M. Mall

Specialty Certification

Pediatrics and Adolescent Medicine
Berlin Medical Association, Germany (2022)

Medical Degree

University of Patras, Greece (2014)

Bachelor's Degree

Nursing
National and Kapodistrian University of Athens, Greece (2009)

• Private Practice Pediatrician, specialising in Pediatric Pulmonology and Pediatric Allergology, Neo Psychiko, Athens, Greece (2026-present)
• External Consultant in Pediatric Pulmonology and Pediatric Allergology, Department of Pediatrics, Metropolitan Hospital, Athens, Greece (2026-present)
• Specialist Physician in Pediatrics and Adolescent Medicine, Department of Pediatrics with a Focus on Pediatric Pulmonology and Immunology, Charité - Universitätsmedizin Berlin, Germany - Clinical practice at a specialised Cystic Fibrosis Centre, participation in research protocols and clinical studies, and undergraduate medical teaching (2022-2026)
• Resident Physician in Pediatrics, Pediatric Clinics and Outpatient Pediatric and Pediatric Cardiology Practices, Germany, including Helios Klinikum Emil von Behring and Evangelisches Krankenhaus Paul Gerhardt Stift (2016-2022)
• Rural Service Physician, Agios Markos Health Centre, Corfu, Greece (2015-2016)

Pediatrics and Adolescent Medicine, Pediatric Pulmonology, Pediatric Allergology and Clinical Immunology, with a particular interest in Cystic Fibrosis, Primary Ciliary Dyskinesia, Paranasal Sinus Imaging and Advanced CFTR Modulator Therapies.

1. Hellenic Society of Pediatric Allergology
2. German Society for Pediatric Pulmonology
3. German Society for Allergology and Clinical Immunology
4. European Cystic Fibrosis Society (ECFS)
5. European Respiratory Society (ERS)
6. Berlin, Athens and Piraeus Medical Associations

1. Aleksander PE, Thee S, Doellinger F, Zagkla S, Mall MA, Stahl M. Prenatal Elexacaftor Tezacaftor Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants with Cystic Fibrosis. Pediatric Pulmonology. 2025.
2. Pioch CO, Ziegahn N, Allomba C, Busack LM, Schnorr AN, Tosolini A, Fuhlrott BR, Zagkla S, et al. Elexacaftor tezacaftor ivacaftor improves nasal nitric oxide in patients with cystic fibrosis. Journal of Cystic Fibrosis. 2024.